6
Clinical Trials associated with GK-664SA Phase 3, Randomized, Double-Blind, Placebo-Controlled Multi-Center, Parallel Group Study to evaluate Efficacy and Safety of GK664S in Subjects with moderate-to-severe scalp Seborrheic dermatitis.
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Multi-Center, Parallel Group Study to evaluate Efficacy and Safety of GK664S in Subjects with moderate-to-severe scalp Seborrheic dermatitis.
A Open-Label Phase 3, Multi-Center, Parallel Group Study to evaluate Efficacy and Safety Study of GK664S in Subjects with moderate-to-severe scalp Eczema Dermatitis except for seborrheic dermatitis.
100 Clinical Results associated with GK-664S
100 Translational Medicine associated with GK-664S
100 Patents (Medical) associated with GK-664S
100 Deals associated with GK-664S